In clinical trials for X-linked Severe Combined Immunodeficiency (SCID-X), for instance, a therapeutic retroviral vector integrated near the LMO-2 proto-oncogene locus and caused leukemia-like illness [10, 11]. The gene discussed is LMO2; the disease is T-B+ severe combined immunodeficiency due to gamma chain deficiency.